The modulation of APOE properties by structural modification through small molecule correctors [161,162], or by inhibiting APOE-Aβ interactions with small molecule inhibitors [163,164], have also been proposed for therapeutic interventions in AD. Here, APOE is linked to Alzheimer disease.